A multicenter randomized clinical trial (Dong et al., 2021) demonstrated that the effect of ginkgolide on ischemic stroke is associated with the platelet activating factor (PAF) pathway, but not with the ADP or thromboxane A2 (TxA2) pathways. This evidence concerns the gene PCLAF and ischemic stroke.